Price and Volume Movers
Trading of Kitov Pharmaceuticals Holdings Ltd. (Nasdaq:KTOV) was halted today by NASDAQ as "additional information was requested” from the company. The halt was enforced just before the opening of the trading session. Shares had dropped 27% to $1.85 in pre-market trading prior to the halt. The company announced following the trading halt that the Israeli Securities Authority has begun a formal investigation into its public disclosures around its lead drug candidate, KIT-302.
Gilead Sciences Inc. (NASDAQ: GILD) shares have dropped over 5% in the after-hours session to $69.15. Investors sold off shares of Gilead following disappointing earnings guidance issued after the bell. 4Q earnings fell from $4.7b to $3.1b, reflecting significantly lower sales of its Hepatitis C drugs Harvoni and Sovaldi. The company expects 2017 net product sales of $22.5b to $24.5b, well below analyst estimates.
Coherus BioSciences, Inc. (Nasdaq:CHRS) announced it has commenced an underwritten public offering of $125m of shares of its common stock. Shares are currently down 6% to $25 in the after-hours session.
Galena Biopharma, Inc. (NASDAQ:GALE) announced it has commenced an underwritten public offering to issue and sell shares of its common stock and warrants to purchase shares of its common stock. Shares have fallen 15% to 1.19 in the after-hours session.
Other major movers:
Acura Pharmaceuticals, Inc.(NASDAQ:ACUR): $1.62; +130%.
MYOS RENS Technology Inc (NASDAQ:MYOS): $4.72; +31%.
Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC): $3.06; +23%.
Catalyst Biosciences Inc (NASDAQ:CBIO): $0.587; +20%.
Concordia International Corp (NASDAQ:CXRX): $3.49; +18%.
Delcath Systems, Inc (NASDAQ:DCTH): $0.251; -17%.
Dimension Therapeutics Inc (NASDAQ:DMTX): $1.65; -13%.
Moleculin Biotech Inc (NASDAQ:MBRX): $1.80; -10%.
Minerva Neurosciences Inc (NASDAQ:NERV): $10.15; -7%.
Alcobra Ltd (NASDAQ:ADHD): $1.21; -7%.
Full pipeline updates: